retatrutide week by week VisualAbstract: reduces body weight 17.5% in patients with obesity 10 weeks progress on retatrutide

The FDA announced on January 13 that it has asked Novo Nordisk and Eli Lilly to remove warnings about suicide and suicidal thoughts from the labels of Saxenda, Wegovy, and Zepbound

Already, many GLP-1 users quit within a year, studies suggest -- often due to side effects, high costs, or insurance issues

Additionally, because many people with diabetes or who are overweight may control their condition with diet, other medications and therapies, or choose to not seek treatment, not all people who meet these clinical criteria would use GLP-1 drugs

What makes Smart Rx clinically meaningful isnt just the price point its that medication access and behavior change are fully integrated into one seamless experience, said Jennifer Jones, MSM RD CSOWM, Director, Clinical Solutions Architect, Noom

The main peak represents your target peptide (retatrutide)

Notably, 77.1% achieved and maintained at least 5% weight loss over the full study period